Skip to main content
Clinical Trials/CTRI/2018/10/015944
CTRI/2018/10/015944
Not yet recruiting
Phase 4

A Comparative Evaluation of Duloxetine and Gabapentin in Painful Diabetic Neuropathy: A Randomised control trial

All India Institute of Medical Sciences Jodhpur0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
Sponsor
All India Institute of Medical Sciences Jodhpur
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
All India Institute of Medical Sciences Jodhpur

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients of either sex with type 2 DM, aged 18 \-75 years, who were on stable glucose\-lowering medications during the preceding month and who had Painful diabetic neuropathy for at least1 month.
  • 2\.Had a pain score of \>50%, as assessed by visual analog scale (VAS).

Exclusion Criteria

  • 1\.If they had any clinically significant or unstable medical or psychiatric illnesses.
  • 2\.Patients with other causes of neuropathy.
  • 3\.Renal dysfunction; liver disease; epilepsy; psychiatric illness; uncontrolled hypertension; malignancy;
  • 4\.Substance abuse; those taking anticonvulsants, antidepressants, local anaesthetics, or opioids;
  • 5\.Pregnant; lactating women; or those being treated with any investigational drug within last 30 days.
  • 6\.If they had Vitamin B12 level less than 200 pg/ml.
  • 7\.Patients with HbA1C levels \> 9 %.

Outcomes

Primary Outcomes

Not specified

Similar Trials